Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

Affiliations

• ¹ Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
• ² Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.
• ³ Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio, USA.
• ⁴ The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
• ⁵ Department of Neurology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School.
• ⁶ Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut, USA.
• ⁷ University of California San Francisco, San Francisco, California, USA.
• ⁸ Department of Neurosurgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
• ⁹ David Geffen School of Medicine, Department of Neurology, University of California Los Angeles, Los Angeles, California, USA.
• ¹⁰ Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ¹¹ Mayo Clinic, Rochester, Minnesota, USA.
• ¹² Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
• ¹³ Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
• ¹⁴ Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
• ¹⁵ Division of Neuroradiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
• ¹⁶ Department of Neurology and Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.
• ¹⁷ University of Lille, Inserm, Neuro-oncology, General and Stereotaxic Neurosurgery service, University Hospital of Lille, Lille, France; Breast Cancer Department, Oscar Lambret Center, Lille, France and Department of Neurology & Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.
• ¹⁸ Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
• ¹⁹ Miami Cancer Institute, Miami, Florida, USA.
• ²⁰ Department of Neurology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
• ²¹ Radiation Oncology Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
• ²² Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California, USA.
• ²³ Department of Neurology, Medical Faculty Mannheim, MCTN, Heidelberg University, Heidelberg, Germany.
• ²⁴ Division of Oncology, Department of Medicine, Medical University of Vienna, Vienna, Austria.
• ²⁵ Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France.
• ²⁶ University of Virginia School of Medicine, Division of Neuro-Oncology, Department of Neurology, University of Virginia, Charlottesville, Virginia, USA.
• ²⁷ Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
• ²⁸ Department of Neurology, Medical Center Haaglanden, The Hague and Department of Neurology, Leiden University Medical Center, the Netherlands.
• ²⁹ Department of Neurosurgery, University Hospital, LMU Munich, Munich, Germany.
• ³⁰ Neuropathology and Clinical Cooperation Unit Neuropathology, University Heidelberg and German Cancer Center, Heidelberg, Germany.
• ³¹ Department of Neurology and Neuro-oncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
• ³² MacFeeters Hamilton Centre for Neuro-Oncology Research, Princess Margaret Cancer Centre, Toronto, Canada.
• ³³ Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
• ³⁴ Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.